Peripheral neuropathy decisions — 2025

The Veteran's appeal for increased ratings was denied, except for a grant of TDIU effective May 30, 2023.

The Board denied service connection for hernia, brain tumor, heart, esophagus, kidney, left lower extremity peripheral neuropathy, right lower extremity peripheral neuropathy, and thyroid. The claim for bilateral hearing loss was remanded.

The Board denied an increased rating for lumbosacral strain but granted separate ratings of 10 percent each for right and left lower extremity neuropathy of the anterior tibial nerve.

The Board remands the claim for a right foot disability, to include plantar fasciitis and neuropathy, as there is no adequate VA medical opinion regarding these conditions.

The Board granted service connection for diabetic retinopathy, peripheral neuropathy of the upper extremities, kidney condition, obstructive sleep apnea, asthma, and tinnitus.

The appeal for an earlier effective date prior to June 6, 2019, for coronary artery disease (CAD) was dismissed due to improper docketing of the appeal.

The Board granted the petitions to reopen previously denied claims for bilateral lower extremity peripheral neuropathy and rash over the entire torso, based on new and material evidence. The claims for service connection were remanded for further consideration.

The Board remands the claims for service connection for peripheral neuropathy in all extremities due to outstanding medical records and unclear diagnoses.

The Board granted service connection for Lewy body dementia with parkinsonism and special monthly compensation (SMC) based on the need for aid and attendance, but denied service connection for skin disability, residuals of shrapnel wounds, bilateral upper and lower extremity peripheral neuropathy, and psychiatric disorder.

The appeal is remanded to correct a pre-decisional duty to assist error by the AOJ.

The Board dismissed the appeals for service connection for left foot, right hand, right foot, and left upper extremity peripheral neuropathy as untimely.

The Board granted a rating of 50 percent for major depressive disorder with alcohol use disorder and cognitive impairment from May 1, 2017 to December 10, 2019; denied a rating in excess of 70 percent from December 11, 2019 to February 6, 2023. The Board granted ratings of 20 percent for right and left lower extremity sciatic nerve peripheral neuropathy from May 1, 2017 to February 6, 2023; denied a rating in excess of 20 percent on and after February 7, 2023. The Board granted an initial 10 percent rating for hypertension effective August 10, 2022.

The Board denied service connection for chronic fatigue syndrome, amyotrophic lateral sclerosis, and arthritis, back condition, peripheral neuropathy of the left lower extremity, and right lower extremity. However, it granted service connection for muscle spasms (RLS) as secondary to a service-connected obstructive sleep apnea.

The Board denied the Veteran's claims for eligibility for specially adapted housing, a special home adaptation grant, and financial assistance in purchasing an automobile or other conveyance and adaptive equipment. The claim of CUE in the September 14, 2017, rating decision was also denied.

The Board granted service connection for Parkinson's disease and denied an initial compensable evaluation for partial loss of sense of smell, mild speech changes, difficulty swallowing (bilateral), and neuropathy in the upper and lower extremities.

The Board denied service connection for obstructive sleep apnea and granted earlier effective dates for the ratings of diabetic peripheral neuropathy in the upper and lower extremities, as well as for hypertension.

The Board remands the issues of entitlement to higher evaluations for left and right lower extremity diabetic neuropathy of the femoral nerves, as well as a claim for special monthly compensation based on housebound status.

The Board denied the veteran's claims for higher ratings and earlier effective dates, except for an earlier effective date for service connection of lower extremity peripheral neuropathy.

The Board granted service connection for coronary artery disease, diabetes mellitus type II, and left and right lower extremity diabetic neuropathy due to exposure to contaminated drinking water at Camp Lejeune during service. Service connection for obstructive sleep apnea was remanded.

The Board granted a 50 percent rating for the Veteran's peripheral neuropathy with carpal tunnel syndrome of the right upper extremity and denied an increased rating in excess of 20 percent for the left upper extremity.